Open in interactive viewer → charts, metric popovers & call review

Mach7's Reset: From Archive to Architecture, a Turnaround in Motion

Mach7 Technologies shifts to recurring revenue, rebuilds customer trust, and bets on Flamingo to orchestrate imaging — but the market needs proof.
M7T.AX · Earnings Call · 2026-08-27

The Reset Year

A year ago, CEO Teri Thomas diagnosed the problem: “Mach7 had lost some of its connection with its customers.” — Teri Thomas, CEO · 2026-08-27 That diagnosis set off a comprehensive reset. In FY26, the company cut operating expenses by 16%, reshaped the workforce, exited long-term leases, and revamped its customer engagement model. The goal was to stabilize, and according to Thomas, “That is what stabilization looks like. It doesn't look spectacular yet, but it is more dependable, and dependable is a really good place from which we can grow.” — Teri Thomas, CEO · 2026-08-27 Financially, the reset took a toll: total revenue fell 17% to $27.9M, with capital license revenue down 17% and recurring revenue down 8%. But the company deliberately shifted from capital sales to subscriptions, replacing "a big piece of upfront revenue with smaller recurring payments." The new modules and subscription conversions are already showing: on a constant currency basis, ARR run rate rose 7.6% year-over-year, even as the VHA and Trinity Health nonrenewals weighed on CAR. Operating cash flow turned positive in 3 of 4 quarters, and second-half revenue jumped 15% over the first half on a constant currency basis. The reset has been years in the making. In earlier calls, Thomas acknowledged the company's weakness: “I think somehow Mach7 over time did a good job with taking care of its staff, organizing the business, but stepped away from that deep understanding of the customers' world, and we need to build that back.” — Teri Thomas, Chief Executive Officer · 2026-01-29 The new "flight crew" model was a direct response to feedback from Trinity Health: “It wasn't about the software. It was about the engagement model, and we've completely changed our engagement model.” — Teri Thomas, CEO · 2025-10-30

Customer-Centric Architecture

The strategic pivot from "archive to architecture" is built on a three-pronged platform: VNA for data management, eUnity for visualization, and Flamingo for orchestration. As Thomas puts it:

We are building. We are building new modules. We're expanding, and we're building an architecture that helps health care organizations move and access medical images, which becomes increasingly valuable as AI creates more demand for well-organized imaging data.

Teri Thomas, CEO · 2026-08-27
The company is expanding beyond traditional radiology into dental, point-of-care ultrasound, and non-DICOM imaging, with a $2.7B addressable market in its primary regions. Notably, eUnity is now published in Epic's connection hub, a major integration milestone. The image exchange trend is both a challenge and an opportunity. As Epic releases diagnostic image exchange, it multiplies copies of images. Mach7 positions itself as the independent layer that organizes it all. "The more the imaging spreads, the more our customers need an independent layer that can organize it and make it usable," Thomas said. Customer experience is increasingly central. KLAS scores for VNA improved from 68.7 to 73.6, and eUnity scored 86.6% above market average. Thomas reads every comment, aiming to be "the customer's best vendor experience." This ties into the best vendor theme that became a company mantra.

Proving the Growth Engine

Now entering Phase 2, Mach7 must prove it can grow. Management's FY27 metrics are clear: ARR growth, new customers, Flamingo adoption, and OpEx discipline. The pipeline is building — 40% of the year's order volume came in Q4, and 86% of orders were ARR-type sales. The company is also strengthening partnerships, concentrating on fewer deeper relationships rather than collecting logos. Sales orders are expected to flow through as the year progresses. Currency headwinds remain a presentation issue, but the natural hedge (100% of CAR in USD, 70% of costs in USD) limits the impact. The balance sheet is strong: $19.9M cash, no debt, and management is not pursuing acquisitions, preferring to demonstrate stability to U.S. healthcare customers. The question is whether the market will buy the turnaround story. With a market cap of just $76M, Mach7 is a small-cap comeback play. The next 12 months will test whether the reset translates into sustained growth. As Thomas puts it, “A year ago, our job was to fix the business. And this year, our job is to prove that a better business can grow.” — Teri Thomas, CEO · 2026-08-27